The Present and Future Global Burden of the Inherited Disorders of Hemoglobin
- PMID: 27040957
- DOI: 10.1016/j.hoc.2015.11.004
The Present and Future Global Burden of the Inherited Disorders of Hemoglobin
Abstract
The inherited disorders of hemoglobin represent the most common monogenic diseases. This article provides a brief description of the main inherited disorders of hemoglobin and their classification, and summarizes progress made in the last decade toward a better awareness and recognition of these disorders as a global health problem. Also presented are the main demographic, genetic, and environmental factors that influence the present and future health burden of these disorders. The strengths and limitations of existing estimates and current health policies in high-, low-, and middle-income countries are discussed.
Keywords: Consanguinity; Genetic disease; Human migrations; Malaria selection; Newborn screening; Public health; Sickle cell disease; Thalassemias.
Copyright © 2016 Elsevier Inc. All rights reserved.
Similar articles
-
World distribution, population genetics, and health burden of the hemoglobinopathies.Cold Spring Harb Perspect Med. 2012 Sep 1;2(9):a011692. doi: 10.1101/cshperspect.a011692. Cold Spring Harb Perspect Med. 2012. PMID: 22951448 Free PMC article. Review.
-
Hemoglobinopathies worldwide: present and future.Curr Mol Med. 2008 Nov;8(7):592-9. doi: 10.2174/156652408786241375. Curr Mol Med. 2008. PMID: 18991645 Review.
-
[Hemoglobinopathies in developing countries].Wien Klin Wochenschr. 1984 Jul 6;96(14):535-9. Wien Klin Wochenschr. 1984. PMID: 6382806 Review. German.
-
The inherited diseases of hemoglobin are an emerging global health burden.Blood. 2010 Jun 3;115(22):4331-6. doi: 10.1182/blood-2010-01-251348. Epub 2010 Mar 16. Blood. 2010. PMID: 20233970 Free PMC article. Review.
-
The challenge of haemoglobinopathies in resource-poor countries.Br J Haematol. 2011 Sep;154(6):736-44. doi: 10.1111/j.1365-2141.2011.08742.x. Epub 2011 Jul 5. Br J Haematol. 2011. PMID: 21726207 Review.
Cited by
-
End Organ Affection in Sickle Cell Disease.Cells. 2024 May 29;13(11):934. doi: 10.3390/cells13110934. Cells. 2024. PMID: 38891066 Free PMC article. Review.
-
Prevalence and Regional Distribution of Beta-Hemoglobin Variants in Saudi Arabia: Insights from the National Premarital Screening Program".J Epidemiol Glob Health. 2024 Sep;14(3):1242-1248. doi: 10.1007/s44197-024-00281-x. Epub 2024 Jul 29. J Epidemiol Glob Health. 2024. PMID: 39073533 Free PMC article.
-
Lived experiences of Iranian parents of beta-thalassemia children.J Multidiscip Healthc. 2017 Jun 29;10:243-251. doi: 10.2147/JMDH.S132848. eCollection 2017. J Multidiscip Healthc. 2017. PMID: 28721064 Free PMC article.
-
Fifteen years of newborn sickle cell disease screening in Madrid, Spain: an emerging disease in a European country.Ann Hematol. 2020 Jul;99(7):1465-1474. doi: 10.1007/s00277-020-04044-z. Epub 2020 May 26. Ann Hematol. 2020. PMID: 32451712
-
Use of genome-editing tools to treat sickle cell disease.Hum Genet. 2016 Sep;135(9):1011-28. doi: 10.1007/s00439-016-1688-0. Epub 2016 Jun 1. Hum Genet. 2016. PMID: 27250347 Free PMC article. Review.
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Other Literature Sources